MARS2 drives metabolic switch of non-small-cell lung cancer cells via interaction with MCU

MARS2通过与MCU相互作用驱动非小细胞肺癌细胞的代谢转换。

阅读:4
作者:Juhyeon Son ,Okkeun Jung ,Jong Heon Kim ,Kyu Sang Park ,Hee-Seok Kweon ,Nhung Thi Nguyen ,Yu Jin Lee ,Hansol Cha ,Yejin Lee ,Quangdon Tran ,Yoona Seo ,Jongsun Park ,Jungwon Choi ,Heesun Cheong ,Sang Yeol Lee

Abstract

Mitochondrial methionyl-tRNA synthetase (MARS2) canonically mediates the formation of fMet-tRNAifMet for mitochondrial translation initiation. Mitochondrial calcium uniporter (MCU) is a major gate of Ca2+ flux from cytosol into the mitochondrial matrix. We found that MARS2 interacts with MCU and stimulates mitochondrial Ca2+ influx. Methionine binding to MARS2 would act as a molecular switch that regulates MARS2-MCU interaction. Endogenous knockdown of MARS2 attenuates mitochondrial Ca2+ influx and induces p53 upregulation through the Ca2+-dependent CaMKII/CREB signaling. Subsequently, metabolic rewiring from glycolysis into pentose phosphate pathway is triggered and cellular reactive oxygen species level decreases. This metabolic switch induces inhibition of epithelial-mesenchymal transition (EMT) via cellular redox regulation. Expression of MARS2 is regulated by ZEB1 transcription factor in response to Wnt signaling. Our results suggest the mechanisms of mitochondrial Ca2+ uptake and metabolic control of cancer that are exerted by the key factors of the mitochondrial translational machinery and Ca2+ homeostasis. Keywords: Cancer metabolism; Epithelial-mesenchymal transition; Mitochondrial calcium uniporter; Mitochondrial methionyl-tRNA synthetase; Reactive oxygen species; p53.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。